As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life. In this interactive, case-driven webinar, participants will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. Expert faculty will guide attendees through mechanisms of action, clinical trial outcomes, real-world evidence, and safety considerations, offering up-to-date insights that bridge cutting-edge research and everyday practice. By the end of this webinar, participants will be equipped with practical strategies to integrate these novel therapies into comprehensive treatment plans, optimize disease monitoring, and collaborate effectively with multidisciplinary teams, ultimately advancing care for children living with IBD.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
40 of 40 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
-
ReleasedFeb 26, 2026
-
Last day to claim creditFeb 27, 2028 1 year left
-
Learner’s Digest International (TM) Advanced Targeted Therapies
-
Vindico Medical Education, LLC TL1A Inhibition for IBD: Emerging Therapies at the Intersection of Inflammation and Fibrosis
-
CME Outfitters, LLC A CaseWise Initiative Mission Possible: Matching Treatment Goals of Patients and Providers in IBD in Clinical Practice
-
North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Clinical Impacts of Immunomodulator Withdrawal from anti-TNF Combination Therapy in Pediatric Inflammatory Bowel Disease JPGN October 2024
-
North American Society for Pediatric Gastroenterology, Hepatology & Nutrition North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease, October 2025 JPGN
-
North American Society for Pediatric Gastroenterology, Hepatology & Nutrition ON DEMAND Crafting New Horizons: Blending Art, Medicine and Novel Techniques in Intestinal Rehabilitation and Transplantation
